New insights into the mechanisms of signal formation in RF-spoiled gradient echo sequences.

Magn Reson Med

Unité de Résonance Magnétique, Imagerie Médicale, Hôpital Erasme, Université Libre de Bruxelles, Belgium.

Published: October 2005

RF spoiling is a well established method to produce T(1)-weighted images with short repetition-time gradient-echo sequences, by eliminating coherent transverse magnetization with appropriate RF phase modulation. This paper presents 2 novel approaches to describe signal formation in such sequences. Both methods rely on the formulation of RF spoiling as a linear increase of the precession angle between RF pulses, which is an alternative to the commonly used quadratic pulse phase scheme. The first technique demonstrates that a steady state signal can be obtained by integrating over all precession angles within the voxel, in spite of the lack of a genuine steady-state for separate isochromats. This clear mathematical framework allows a straightforward incorporation of off-resonance effects and detector phase settings. Moreover, it naturally introduces the need for a large net gradient area per repetition interval. In the second step, a modified partition method including RF spoiling is developed to obtain explicit expressions for all signal components. This provides a physical interpretation of the deviations from ideal spoiling behavior in FLASH and echo-shifted sequences. The results of the partition method in the small flip angle regime are compared with numerical simulations based on a Fourier decomposition of magnetization states. Measurements performed with in vitro solutions were in good agreement with numerical simulations at short relaxation times (T(1)/TR = 32 and T(2)/TR = 4); larger deviations occurred at long relaxation times (T(1)/TR = 114 and T(2)/TR = 82).

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrm.20652DOI Listing

Publication Analysis

Top Keywords

signal formation
8
partition method
8
numerical simulations
8
relaxation times
8
times t1/tr
8
insights mechanisms
4
signal
4
mechanisms signal
4
formation rf-spoiled
4
rf-spoiled gradient
4

Similar Publications

Background And Aim: The high rate of tumor growth results in an increased need for amino acids. As solute carriers (SLC) transporters are capable of transporting different amino acids, cancer may develop as a result of these transporters' over-expression due to their complex formation with other biological molecules. Therefore, this review investigated the role of SLC transporters in the progression of cancer.

View Article and Find Full Text PDF

Introduction: The mechanism of remimazolam, a benzodiazepine that activates γ-aminobutyric acid a (GABAa) receptors, in cerebral ischemia/reperfusion (I/R) injury is not well understood. Therefore, we explored whether remimazolam activates protein kinase B (AKT)/glycogen synthase kinase-3β (GSK-3β)/nuclear factor erythroid 2-related factor 2 (NRF2) to attenuate brain I/R injury in transcerebral I/R-injured rats and transoxygenic glucose deprivation/reperfusion (OGD/R)-injured SY5Y cells.

Material And Methods: Remimazolam was added at the beginning of cell and rat reperfusion, and the PI3K/AKT inhibitor LY294002 was added to inhibit the AKT/GSK-3β/NRF2 pathway 24 h before cellular OGD/R treatment and 30 min before rat brain I/R treatment.

View Article and Find Full Text PDF

Thio-ProTide strategy: A novel HS donor-drug conjugate (DDC) alleviates hepatic injury innate lysosomal targeting.

Acta Pharm Sin B

December 2024

Key Laboratory of Drug Metabolism and Pharmacokinetics, Research Unit of PK-PD Based Bioactive Components and Pharmacodynamic Target Discovery of Natural Medicine of Chinese Academy of Medical Sciences, China Pharmaceutical University, Nanjing 210009, China.

Hydrogen sulfide (HS) is a gas signaling molecule with versatile bioactivities; however, its exploitation for disease treatment appears challenging. This study describes the design and characterization of a novel type of HS donor-drug conjugate (DDC) based on the thio-ProTide scaffold, an evolution of the ProTide strategy successfully used in drug discovery. The new HS DDCs achieved hepatic co-delivery of HS and an anti-fibrotic drug candidate named hydronidone, which synergistically attenuated liver injury and resulted in more sufficient intracellular drug exposure.

View Article and Find Full Text PDF

Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy.

Acta Pharm Sin B

December 2024

School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.

The fat mass and obesity-associated protein (FTO) is an RNA demethylase required for catalytic demethylation of -methyladenosine (mA); it is highly expressed and functions as an oncogene in acute myeloid leukemia (AML). Currently, the overarching objective of targeting FTO is to precisely inhibit the catalytic activity. Meanwhile, whether FTO degradation also exerts antileukemic effects remains unknown.

View Article and Find Full Text PDF

Pretheranostic agents with extraordinaryNIRF/photoacoustic imaging performanceand photothermal oncotherapy efficacy.

Acta Pharm Sin B

December 2024

Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.

Cervical cancer, the most common gynecological malignancy, significantly and adversely affects women's physical health and well-being. Traditional surgical interventions and chemotherapy, while potentially effective, often entail serious side effects that have led to an urgent need for novel therapeutic methods. Photothermal therapy (PTT) has emerged as a promising approach due to its ability to minimize damage to healthy tissue.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!